Comparison of Regulatory Requirements for Pharmaceuticals in Non- European Union Member States Kosovo, Ukraine and Serbia

S. Jani, Nilesh Patel, Urvi Chotaliya, Ashok R. Patel
{"title":"Comparison of Regulatory Requirements for Pharmaceuticals in Non- European Union Member States Kosovo, Ukraine and Serbia","authors":"S. Jani, Nilesh Patel, Urvi Chotaliya, Ashok R. Patel","doi":"10.2174/2213476X06666190624152156","DOIUrl":null,"url":null,"abstract":"\n\nLiterature review suggested that regulatory guidelines should be harmonized\nfor better processing of applications and for the upliftment of the regulatory field. Therefore\nit was thought worthwhile to compare the guidelines for countries where there is requirement of\nharmonization. Kosovo, Ukraine and Serbia were selected because of being European countries\nand still they are not a part of EU.\n\n\n\nKosovo, Ukraine and Serbia are small countries of Europe but they are not members\nof European Union. They have their own guidelines for the submission of MAA for marketing\nof pharmaceuticals and medical devices. They are trying to obtain the EU membership and\ntherefore it was worthwhile to compare the guidelines of these countries.\n\n\n\nThe registration process of pharmaceuticals in Kosovo, Ukraine and Serbia was studied\nthroughly. Along with it, the guidelines for European Union were also studied. A comparison of\nguidelines of all the three countries with the guidelines of European Union for pharmaceuticals\nwas carried out.\n\n\n\nThe comparison of guidelines showed that there are still some changes needed in the\nguidelines of Kosovo, Ukraine and Serbia before they can merge with the guidelines of European\nUnion. Some of the points in the guidelines are very different from the guidelines of EU.\n\n\n\nSo it was worthwile to study the regulatory requirements of pharmaceuticals in Non-\nEuropean Union Member States Kosovo, Ukraine and Serbia.\n","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2213476X06666190624152156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Literature review suggested that regulatory guidelines should be harmonized for better processing of applications and for the upliftment of the regulatory field. Therefore it was thought worthwhile to compare the guidelines for countries where there is requirement of harmonization. Kosovo, Ukraine and Serbia were selected because of being European countries and still they are not a part of EU. Kosovo, Ukraine and Serbia are small countries of Europe but they are not members of European Union. They have their own guidelines for the submission of MAA for marketing of pharmaceuticals and medical devices. They are trying to obtain the EU membership and therefore it was worthwhile to compare the guidelines of these countries. The registration process of pharmaceuticals in Kosovo, Ukraine and Serbia was studied throughly. Along with it, the guidelines for European Union were also studied. A comparison of guidelines of all the three countries with the guidelines of European Union for pharmaceuticals was carried out. The comparison of guidelines showed that there are still some changes needed in the guidelines of Kosovo, Ukraine and Serbia before they can merge with the guidelines of European Union. Some of the points in the guidelines are very different from the guidelines of EU. So it was worthwile to study the regulatory requirements of pharmaceuticals in Non- European Union Member States Kosovo, Ukraine and Serbia.
非欧盟成员国科索沃、乌克兰和塞尔维亚药品监管要求的比较
文献综述表明,为了更好地处理申请和提升监管领域,监管指南应该协调一致。因此,人们认为有必要对有统一要求的国家的准则进行比较。科索沃、乌克兰和塞尔维亚被选中是因为它们是欧洲国家,但它们仍然不是欧盟的一部分。科索沃、乌克兰和塞尔维亚是欧洲的小国,但它们不是欧盟成员国。对于药品和医疗器械的销售,他们有自己的MAA提交指南。他们正在努力获得欧盟成员资格,因此比较这些国家的指导方针是值得的。对科索沃、乌克兰和塞尔维亚药品注册过程进行了全面研究。与此同时,还研究了欧盟的指导方针。将这三个国家的指南与欧盟药品指南进行了比较。这些准则的比较表明,科索沃、乌克兰和塞尔维亚的准则在与欧盟的准则合并之前还需要进行一些修改。指导方针中的一些要点与欧盟的指导方针有很大不同。因此,对非欧盟成员国科索沃、乌克兰和塞尔维亚的药品监管要求进行研究是值得的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信